Anticoagulants, Antiplatelets & Antihaemorrhagics
Rivaroxaban in four strengths, 2.5, 10, 15 and 20 mg, and apixaban at 2.5 and 5 mg hold the factor Xa end of this cardiology shelf. The antiplatelet end is clopidogrel at 75 mg, ticagrelor at 90 mg and gastro-resistant acetylsalicylic acid at 75 and 100 mg, and tranexamic acid at 100 mg per ml in 5 ml ampoules stops the bleeding in theatre and the delivery room. The 16 formulations start at 10,000 units, made in Spain and other countries.
Rivaroxaban in four strengths, 2.5, 10, 15 and 20 mg, and apixaban at 2.5 and 5 mg hold the factor Xa end of this cardiology shelf. The antiplatelet end is clopidogrel at 75 mg, ticagrelor at 90 mg, gastro-resistant acetylsalicylic acid at 75 and 100 mg and tirofiban at 12.5 mg per 50 ml as a concentrate for infusion for the catheter laboratory, and tranexamic acid at 100 mg per ml in 5 ml ampoules stops the bleeding in theatre and the delivery room. 17 formulations, from 10,000 units.
Shipping and document legalisation for your country are calculated separately and stated in the offer.